Besides the increased pro-inflammatory markers, obesity is often associated with a decrease in adiponectin, an anti-inflammatory adipokine deemed beneficial against dyslipidemia and important in maintaining glucose and insulin homeostasis [34,177,178]. This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.